Sanofi Consumer Healthcare India Limited

BSE: SANOFICONR544250ISIN INE0UOS01011

Healthcare
Pharmaceuticals
BSE 1000

BSE listing

Share price

₹4,015.85+12.90 (+0.32%)

as of 18 Sep 2026

52W high: ₹5,355.00
52W low: ₹3,950.50
Off 52W high: -25.01%
1M return: -4.93%
3M return: -16.65%
6M return: -5.66%
1Y return: -23.99%
20D avg volume: 542
50 DMA: ₹4,368.68
200 DMA: ₹4,462.27

Key ratios Standalone

Market cap: ₹9,249 Cr
Current price: ₹4,015.85
52W high / low: ₹5,355.00 / ₹3,950.50
Face value: ₹10.00
P/E: 34.77
P/B: 33.88
EPS (TTM): ₹115.50
Book value / share: ₹118.53
ROE: 97.44%
ROCE: —
Operating margin: 40.56%
Net margin: 29.19%
Debt / equity: —
Net debt: —
Interest cover: 161.15
Dividend yield: 1.87%
Dividend / share (TTM): ₹75.00
Payout: 64.94%
Cash conversion cycle: —

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25
Income statement
	235.70	229.20	251.00	233.90	220.90	172.60	—
	6.30	5.60	4.60	3.00	5.60	5.20	—
	150.10	144.10	165.10	152.80	154.20	111.00	—
	47.50	40.20	49.90	36.50	55.40	18.90	—
	16.00	18.10	6.10	26.00	4.60	33.50	—
	31.30	33.10	35.50	31.70	32.00	29.60	—
	0.40	0.50	0.50	0.60	0.50	0.40	—
	3.30	3.20	3.40	3.30	3.00	2.00	—
	58.80	51.10	57.40	55.40	57.50	40.20	—
	91.90	90.70	90.50	84.10	72.30	66.80	—
	0.00	0.00	0.00	0.00	6.60	0.00	—
	91.90	90.70	90.50	84.10	78.90	66.80	—
	23.10	22.90	24.00	21.20	18.20	16.80	—
	68.80	67.80	66.50	62.90	60.70	50.00	—
	29.87	29.44	28.87	27.31	26.36	21.69	—
Key metrics
	95.60	94.40	94.40	88.00	82.40	69.20	—
	40.60%	41.20%	37.60%	37.60%	37.30%	40.10%	—
	29.20%	29.60%	26.50%	26.90%	27.50%	29.00%	—
	24.30%	—	21.70%	—	27.50%	—	—
	6.70%	32.80%	—	—	—	—	—
	13.30%	35.60%	—	—	—	—	—

Metric	TTM	FY26
Income statement
	949.80	878.40
	19.50	18.40
	612.10	583.10
	174.10	160.70
	66.20	70.20
	131.60	128.80
	2.00	2.00
	13.20	11.70
	222.70	210.50
	357.20	313.70
	0.00	6.60
	357.20	320.30
	91.20	80.20
	266.00	240.10
	115.49	104.27
Key metrics
	372.40	334.00
	39.21%	38.00%
	28.01%	27.30%
	—	269.80
	—	1.16
Cash flow
	—	277.40
	—	-7.60
	—	-221.90
	—	7.60

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 71.28%

Holder	Type	Holding	Previous	Change
Opella Healthcare Participations B.V.	Promoter	60.40%	—	—
Opal Bidco SAS	Promoter Group	10.88%	—	—
Nippon Life India Trustee Ltd- A/C Nippon India Growth Mid Cap Fund	Public	5.21%	—	—
Aditya Birla Sun Life Trustee Private Limited A/C - Aditya Birla Sun Life Large Cap Fund	Public	3.03%	—	—
Hdfc Life Insurance Company Limited	Public	2.12%	—	—
Icici Prudential Smallcap Fund	Public	1.57%	—	—
Sbi Dividend Yield Fund	Public	1.47%	—	—
General Insurance Corporation Of India	Public	1.30%	—	—
Bajaj Life Insurance Limited	Public	1.06%	—	—
OH Egypt LLC	Promoter Group	0.00%	—	—
OH Italy S.r.l	Promoter Group	0.00%	—	—
OH Gulf FZE	Promoter Group	0.00%	—	—
Opella Canada Inc.	Promoter Group	0.00%	—	—
OH (Malaysia) Sdn. Bhd.	Promoter Group	0.00%	—	—
OH Hungary K.F.T.	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Copy of Newspaper Publication of Unaudited Financial Results for the quarter and half year ended 30th June 2026 is enclosed.30 Jul 2026 · Company Update / Newspaper Publication
The Board of Directors at its meeting held on Tuesday, 28th July 2026, considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026. In this ....28 Jul 2026 · Company Update / Press Release / Media Release
Unaudited Financial Results for the quarter and half year ended June 30, 2026 is enclosed.28 Jul 2026 · Result / Financial Results
We wish to inform you that the Board of Directors at its meeting held today, i.e. Tuesday, 28th July 2026, inter alia considered and approved the Unaudited Financial Results for the quarter ....28 Jul 2026 · Board Meeting / Outcome of Board Meeting
Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider and approve the Unaudited ....22 Jul 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 3oth June 2026 is enclosed.9 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Appointment of Statutory Auditor of the Company.29 Jun 2026 · Company Update / Appointment of Statutory Auditor/s
Please find eclosed Voting Results and Consolidated Scrutinizer''s Report of the 3rd Annual General Meeting held on 26th June 202629 Jun 2026 · AGM/EGM / AGM
Please find enclosed summary of proceeding of the 3rd Annual General Meeting of the Company held today.26 Jun 2026 · AGM/EGM / AGM
Intimation for Closure of Trading Window.26 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Advertisement of 3rd Annual General Meeting is enclosed.5 Jun 2026 · Company Update / Newspaper Publication
Business Responsibility and Sustainability Report for FY 2025 is enclosed.4 Jun 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Notice of 3rd AGM of the Company is enclosed4 Jun 2026 · AGM/EGM / AGM
Please find enclosed Annual Report for Financial Year 2025.4 Jun 2026 · Others / Reg. 34 (1) Annual Report
Please find enclosed copies of newspaper advertisements regarding convening of 3rd Annual General Meeting of the Company scheduled to be held on 26th June 2026, through VC/OAVM facility.2 Jun 2026 · Company Update / Newspaper Publication
The record date for payment of final dividend for FY 2025 is Friday, 19th June 202627 May 2026 · Corp. Action / Record Date
The Register of Member and Share Transfer Book of the Company will remain closed from Saturday, 20th June 2026 to Friday, 26th June 2026.27 May 2026 · Corp. Action / Book Closure
This is to inform you that the 3rd Annual General Meeting of the Company will be held on Friday, 26th June 2026 through VC/OAVM facility.27 May 2026 · AGM/EGM / AGM
Appointment of M/s. Price Waterhouse & Co Chartered Accountants LLP as the Statutory Auditors of the Company to fill the casual vacancy and hold officer for a period of 5 (five) consecutive ....25 May 2026 · Company Update / Appointment of Statutory Auditor/s
Appointment of M/s. Price Waterhouse & Co Chartered Accountants LLP as the Statutory Auditors of the Company to fill the casual vacancy and hold office for a period of 5 (five) consecutive ....25 May 2026 · Others / Outcome without intimation
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon India Mutual Fund5 May 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
This is to inform you that M/s. Kalyaniwalla & Mistry LLP, Chartered Accountants have tendered their resignation as Statutory Auditor of the Company with immediate effect.30 Apr 2026 · Company Update / Resignation of Statutory Auditors
Copy of Newspaper Publication of Unaudited Financial Result for the quarter ended 31st March 2026 is enclosed.30 Apr 2026 · Company Update / Newspaper Publication
The Board of Directors at its meeting held on Tuesday, 28th April 2026, considered and approved the Unaudited Financial Results for the quarter ended 31st March 2026. In this regard, please ....30 Apr 2026 · Company Update / Press Release / Media Release
Unaudited Financial Results for the quarter ended March 31, 2026 is enclosed.28 Apr 2026 · Result / Financial Results
We wish to inform you that the Board of Directors at its meeting held today i.e., Tuesday 28th April 2026, inter alia considered and approved the Unaudited Financial Results for the quarter ....28 Apr 2026 · Board Meeting / Outcome of Board Meeting
Please find enclosed Report of Scrutinizer dated 23rd April 2026 issued by M/s. MMJB & Associates LLP23 Apr 2026 · AGM/EGM / Postal Ballot
Please find enclosed Voting Results for Postal Ballot Notice dated 25th February 202623 Apr 2026 · AGM/EGM / Postal Ballot
Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2026 ,inter alia, to consider and approve the Unaudited ....23 Apr 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2026 is enclosed.9 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026 is enclosed.27 Mar 2026 · Company Update / Earnings Call Transcript
The video recording of SCHIL Institutional Investor Meet held on Tuesday, 24th March 2026 has been uploaded on the website of the Company.26 Mar 2026 · Company Update / Analyst / Investor Meet
Intimation for Closure of Trading Window25 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Copy of Investor Presentation is enclosed.24 Mar 2026 · Company Update / Investor Presentation
Sanofi Consumer Healthcare India Ltd has submitted to BSE a copies of the Postal Ballot Notice of the Company published on March 24, 2026 in the newspapers.24 Mar 2026 · AGM/EGM / Postal Ballot
Intimation of Dispatch of Postal Ballot Notice to the Shareholders23 Mar 2026 · AGM/EGM / Postal Ballot
Intimation of Schedule of Institutional Investor Meet19 Mar 2026 · Company Update / Analyst / Investor Meet
Submission of Annual Secretarial Compliance Report for the Financial Year ended 31st December 20251 Mar 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Newspaper Publication of Audited Financial Results for the Quarter and Financial Year ended 31st December 202527 Feb 2026 · Company Update / Newspaper Publication
The Board of Directors at its meeting held today designated Mr. Viral Shah, Director, External Manufacturing as Senior Management Personnel of the Company.25 Feb 2026 · Company Update / Change in Management

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 75.0000	19 Jun 2026	19 Jun 2026	—
Final Dividend - Rs. - 55.0000	17 Apr 2025	17 Apr 2025	—

Board meetings

28 Jul 2026 Board Meeting - Financial Results